North America Gene Expression Market Report and Forecast 2024-2032

North America Gene Expression Market Outlook

North America gene expression market size was valued at USD 2.03 billion in 2023, driven by the rapid advancement in the field of genomics in the region. The market is expected to grow at a CAGR of 8.5% during the forecast period of 2024-2032, with the values likely to rise from USD 2.21 billion in 2024 to USD 4.25 billion by 2032. 

Key Takeaways

• In 2024, new cancer cases are projected to surpass 2 million in a year in the United States. The rising demand for precision oncology, fuelled by growing incidence rates of cancer, is expected to drive market growth.

• In December 2023, Neurogene Inc., concluded a merger deal with Neoleukin Therapeutics, Inc. The partnership worth USD 200 million is intended towards developing differentiated genetic therapies for the treatment of complex neurological diseases.

• In March 2023, Illumina Inc., announced the launch of its new Illumina Complete Long Read technology called Illumina Complete Long Read Prep, Human. It the first-ever product that allows access to both long- and short-read data on the same Illumina instrument.

North America Gene Expression Market Analysis

The market growth is driven by advancements in gene expression analysis, which can help to define tumor subtypes and offer a more targeted approach towards cancer treatment. The rising incidence of cancer coupled with the growing patient inclination towards precision oncology is likely to augment market demand. In 2024, new cancer cases are projected to surpass 2 million in a year in the United States, with the estimates suggesting 5,500 cancer diagnoses in a day and over 611,000 deaths in the year. Insights from gene expression analysis can aid oncologists in providing tailored treatment to the huge patient population, thereby driving North America gene expression market growth.

In December 2023, Neurogene Inc., a United States-based biotechnology company specializing in genetic medicines, concluded a merger deal with Neoleukin Therapeutics, Inc., a biopharmaceutical company creating next-generation immunotherapies. The merged business, expected to hold cash worth USD 200 million on closure, plans to focus on the development of differentiated genetic therapies for the treatment of complex neurological diseases including Rett Syndrome. Such merger and acquisition activities are expected to propel the demand for gene expression analysis tools and services, which is likely to boost the market share in the region.

The market is witnessing technological innovations in DNA-sequencing and array-based technologies, which are anticipated to drive North America gene expression market demand. In March 2023, Illumina Inc., announced the launch of its new Illumina Complete Long Read technology called Illumina Complete Long Read Prep, Human. Designated as the first-ever product that allows access to both long- and short-read data on the same Illumina instrument, it is compatible with Illumina NovaSeq X Plus, NovaSeq X, and NovaSeq 6000 Sequencing System. Illumina Complete Long Reads demonstrated accuracy and flexibility, as evidenced by early customer data. The launch of such technologically advanced products which address the limitations associated with long-read technologies and reduce associated costs is likely to support North America gene expression market share in the forecast period.

Other factors that drive the market are the increased application of gene expression profiling in understanding the molecular mechanisms in various diseases, biomarker discovery, drug development, and precision medicine, among others. Moreover, the advancement in healthcare infrastructure and increased investment in research and development are also expected to boost market size.

North America Gene Expression Market Segmentation

The report offers a detailed analysis of the market based on the following segments:

North America Gene Expression Market: Competitor Landscape

The key features of the market report include patent analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:

• Thermo Fisher Scientific Inc.

• GE Healthcare

• QIAGEN N.V.

• Life Technologies

• Agilent Technologies

• PerkinElmer

• Bio-Rad Laboratories

• Roche Diagnostics

• Oxford Gene Technology

• Luminex Corporation

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Highlights of the Report

North America Gene Expression Market Report Snapshots

North America Gene Expression Market Size

North America Gene Expression Market Analysis

North America Gene Expression Companies